PDGFRB and neoplasm: The other patient tested positive for platelet-derived growth factor receptors-α (PDGFR-α) and platelet-derived growth factor receptors-β (PDGFR-β) and received oral imatinib mesylate treatment but unfortunately died due to tumor metastasis after 21 months of follow-up.